Fig. 1From: Higher sensitive selective spectrofluorometric determination of ritonavir in the presence of nirmatrelvir: application to new FDA approved co-packaged COVID-19 pharmaceutical dosage and spiked human plasmaStructural formula of nirmatrelvir and ritonavirBack to article page